{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:42:50Z","timestamp":1791582170890,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.idc.2021.03.010","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:23:19Z","timestamp":1621300999000},"page":"453-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Coccidioidomycosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Derek J.","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0020002","article-title":"Coccidioidomycosis--a fungal disease of the Americas","volume":"2","author":"Hector","year":"2005","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jama.1997.03540350054033","article-title":"A\u00a0coccidioidomycosis outbreak following the Northridge, Calif, earthquake","volume":"277","author":"Schneider","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2021.03.010_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4049\/jimmunol.92.5.779","article-title":"Fungal multiplication and histopathologic changes in vaccinated mice infected with Coccidioides immitis","volume":"92","author":"Kong","year":"1964","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib4","doi-asserted-by":"crossref","first-page":"e0129522","DOI":"10.1371\/journal.pone.0129522","article-title":"Coccidioides endospores and spherules draw strong chemotactic, adhesive, and phagocytic responses by individual human neutrophils","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2021.03.010_bib5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3389\/fimmu.2019.02188","article-title":"The rise of Coccidioides: forces against the dust devil unleashed","volume":"10","author":"Van Dyke","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.idc.2015.10.008","article-title":"Coccidioidomycosis","volume":"30","author":"Stockamp","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2021.03.010_bib7","first-page":"185","article-title":"Coccidioidomycosis: epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1378\/chest.31.1.35","article-title":"Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin","volume":"31","author":"Edwards","year":"1957","journal-title":"Dis Chest"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00484-006-0065-4","article-title":"Statistical modeling of valley fever data in Kern County, California","volume":"51","author":"Talamantes","year":"2007","journal-title":"Int J Biometeorol"},{"issue":"16","key":"10.1016\/j.idc.2021.03.010_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM199504203321607","article-title":"Coccidioidomycosis","volume":"332","author":"Stevens","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib12","first-page":"330","article-title":"The use of coccidioidin","volume":"57","author":"Smith","year":"1948","journal-title":"Am Rev Tuberc"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dc.21613","article-title":"An atypical morphologic presentation of Coccidioides spp. in fine-needle aspiration of lung","volume":"40","author":"Schuetz","year":"2012","journal-title":"Diagn Cytopathol"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib15","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1128\/JCM.36.12.3721-3723.1998","article-title":"Misleading manifestations of Coccidioides immitis in\u00a0vivo","volume":"36","author":"Kaufman","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5858\/2006-130-97-UFOISC","article-title":"Unusual forms of immature sporulating Coccidioides immitis diagnosed by fine-needle aspiration biopsy","volume":"130","author":"Ke","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcp\/99.5.582","article-title":"Fine-needle aspiration biopsy of pulmonary coccidiodomycosis. Spectrum of cytologic findings in 73 patients","volume":"99","author":"Raab","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01277-17","article-title":"Multicenter Clinical Validation of a Cartridge-Based Real-Time PCR System for Detection of Coccidioides spp. in Lower Respiratory Specimens","volume":"56","author":"Saubolle","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/civ388","article-title":"The return of delayed-type hypersensitivity skin testing for coccidioidomycosis","volume":"61","author":"Wack","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1078345818792679","article-title":"Risk Stratification With Coccidioidal Skin Test to Prevent Valley Fever Among Inmates, California, 2015","volume":"24","author":"Wheeler","year":"2018","journal-title":"J\u00a0Correct Health Care"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11046-019-00356-5","article-title":"An analysis of skin test responses to spherulin-based coccidioidin (Spherusol((R))) among a group of subjects with various forms of active coccidioidomycosis","volume":"184","author":"Ampel","year":"2019","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/srin.2001.29315","article-title":"Serologic studies in coccidioidomycosis","volume":"16","author":"Pappagianis","year":"2001","journal-title":"Semin Respir Infect"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01318-18","article-title":"Coccidioidomycosis complement fixation titer trends in the age of antifungals","volume":"56","author":"McHardy","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JCM.01843-09","article-title":"False-positive IgM serology in coccidioidomycosis","volume":"48","author":"Kuberski","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CVI.00531-12","article-title":"Clinical specificity of the enzyme immunoassay test for coccidioidomycosis varies according to the reason for its performance","volume":"20","author":"Blair","year":"2013","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.idc.2021.03.010_bib26","article-title":"Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of coccidioidomycosis","author":"Donovan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.010_bib27","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/JCM.00631-12","article-title":"Serum (1->3)-beta-D-glucan measurement in coccidioidomycosis","volume":"50","author":"Thompson","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib28","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","article-title":"beta-D-glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"Theel","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2021.03.010_bib29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cid\/civ585","article-title":"Role of coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of coccidioidal meningitis","volume":"61","author":"Kassis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.010_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/myc.12366","article-title":"Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis","volume":"58","author":"Bamberger","year":"2015","journal-title":"Mycoses"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.36.12.1394","article-title":"Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases","volume":"36","author":"Smith","year":"1946","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.idc.2021.03.010_bib32","article-title":"Natural history of disseminated coccidioidomycosis: examination of the VA-Armed Forces database","author":"Bays","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/319203","article-title":"Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996","volume":"32","author":"Rosenstein","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk factors for disseminated coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib35","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid1206.060028","article-title":"Coccidioidomycosis as a common cause of community-acquired pneumonia","volume":"12","author":"Valdivia","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/14787210.2014.960849","article-title":"Fungal infections of the skin and nail: new treatment options","volume":"12","author":"Eldridge","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1055\/s-0031-1295723","article-title":"Pulmonary coccidioidomycosis","volume":"32","author":"Thompson","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1439-0507.2012.02224.x","article-title":"Does the presence of mediastinal adenopathy confer a risk for disseminated infection in immunocompetent persons with pulmonary coccidioidomycosis?","volume":"56","author":"Mayer","year":"2013","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1378\/chest.12-1312","article-title":"Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid","volume":"143","author":"Thompson","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rmed.2007.11.014","article-title":"Pleural effusion in hospitalized patients with Coccidioidomycosis","volume":"102","author":"Merchant","year":"2008","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib42","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/cid\/cit114","article-title":"Pediatric coccidioidomycosis in central California: a retrospective case series","volume":"56","author":"McCarty","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.010_bib43","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.idc.2021.03.010_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-014-9816-7","article-title":"Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease","volume":"179","author":"Thompson","year":"2015","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/595687","article-title":"Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis","volume":"48","author":"Ampel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/cid\/cir410","article-title":"Coccidioidomycosis during pregnancy: a review and recommendations for management","volume":"53","author":"Bercovitch","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1513\/AnnalsATS.201308-286FR","article-title":"Update on the diagnosis of pulmonary coccidioidomycosis","volume":"11","author":"Malo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.idc.2021.03.010_bib48","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/archinte.1985.00360080103015","article-title":"Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia","volume":"145","author":"Pont","year":"1985","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2017161659","article-title":"Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017","volume":"284","author":"MacMahon","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4065\/83.3.343","article-title":"Coccidioidomycosis","volume":"83","author":"Parish","year":"2008","journal-title":"Mayo Clinic Proc"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib51","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cid\/cir642","article-title":"Treatment of refractory coccidioidomycosis with voriconazole or posaconazole","volume":"53","author":"Kim","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archsurg.2011.656a","article-title":"Image of the month. Disseminated coccidioidomycosis","volume":"147","author":"Nelson","year":"2012","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00005-13","article-title":"Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis","volume":"26","author":"Nguyen","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.amjmed.2011.10.018","article-title":"Vertebral coccidioidomycosis: presentation and multidisciplinary management","volume":"125","author":"Szeyko","year":"2012","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/clind\/16.2.247","article-title":"The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958","volume":"16","author":"Vincent","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.010_bib56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-133-9-200011070-00009","article-title":"Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group","volume":"133","author":"Galgiani","year":"2000","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib57","doi-asserted-by":"crossref","first-page":"e64249","DOI":"10.1371\/journal.pone.0064249","article-title":"Routine CSF analysis in coccidioidomycosis is not required","volume":"8","author":"Thompson","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis","volume":"42","author":"Johnson","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib59","doi-asserted-by":"crossref","first-page":"ofz241","DOI":"10.1093\/ofid\/ofz241","article-title":"Factors associated with ventriculoperitoneal shunt placement in patients with cryptococcal meningitis","volume":"6","author":"Baddley","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01384-18","article-title":"Examination of fluconazole-induced alopecia in an animal model and human cohort","volume":"63","author":"Thompson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/cix318","article-title":"Adjunctive corticosteroid therapy in the treatment of coccidioidal meningitis","volume":"65","author":"Thompson","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-119-1-199307010-00005","article-title":"Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group","volume":"119","author":"Galgiani","year":"1993","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-198105000-00001","article-title":"Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature","volume":"60","author":"Bouza","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MD.0b013e3181f378a8","article-title":"Coccidioidal meningitis: clinical presentation and management in the fluconazole era","volume":"89","author":"Mathisen","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Supplement_1","key":"10.1016\/j.idc.2021.03.010_bib67","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/mmy\/myy019","article-title":"Coccidioidomycosis in selected immunosuppressed hosts","volume":"57","author":"Blair","year":"2019","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.idc.2021.03.010_bib68","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1086\/444502","article-title":"Coccidioidomycosis in persons infected with HIV type 1","volume":"41","author":"Ampel","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.010_bib69","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1982.00340160069017","article-title":"Coccidioidomycosis in renal replacement therapy","volume":"142","author":"Cohen","year":"1982","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib71","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tid.12372","article-title":"Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation","volume":"17","author":"Mendoza","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib72","doi-asserted-by":"crossref","first-page":"ofaa167","DOI":"10.1093\/ofid\/ofaa167","article-title":"Coccidioidomycosis in patients treated with ruxolitinib","volume":"7","author":"Kusne","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.idc.2020.02.010","article-title":"Fungal infections potentiated by biologics","volume":"34","author":"Davis","year":"2020","journal-title":"Infect Dis Clin North Am"},{"issue":"Supplement_1","key":"10.1016\/j.idc.2021.03.010_bib74","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.idc.2021.03.010_bib75","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/mmy\/myv047","article-title":"In\u00a0vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy","volume":"53","author":"Hodge","year":"2015","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.idc.2021.03.010_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02293-17","article-title":"Evaluation of Amphotericin B lipid formulations for treatment of severe coccidioidomycosis","volume":"62","author":"Sidhu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","article-title":"Liposomal Amphotericin B as monotherapy in relapsed coccidioidal meningitis","volume":"183","author":"Stewart","year":"2018","journal-title":"Mycopathologia"},{"issue":"8","key":"10.1016\/j.idc.2021.03.010_bib78","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.46.8.2420-2426.2002","article-title":"Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits","volume":"46","author":"Clemons","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib79","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/AAC.01538-08","article-title":"Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits","volume":"53","author":"Clemons","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-9343(90)90339-F","article-title":"Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group","volume":"89","author":"Graybill","year":"1990","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2021.03.010_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00400-20","article-title":"Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults","volume":"64","author":"Thompson","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01723-18","article-title":"Effects of food and omeprazole on a novel formulation of super bioavailability itraconazole in healthy subjects","volume":"62","author":"Lindsay","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2021.03.010_bib84","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/myc.12749","article-title":"Itraconazole induced hypertension and hypokalemia: mechanistic evaluation","volume":"61","author":"Hoffmann","year":"2018","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib85","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy","volume":"74","author":"Davis","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02634-16","article-title":"Large-scale evaluation of in\u00a0vitro amphotericin b, triazole, and echinocandin activity against coccidioides species from U.S. Institutions","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80371-4","article-title":"Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group","volume":"98","author":"Catanzaro","year":"1995","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.010_bib88","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.01148-07","article-title":"Voriconazole use for endemic fungal infections","volume":"53","author":"Freifeld","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.05275-11","article-title":"Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles","volume":"56","author":"Thompson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib90","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/cid\/cir734","article-title":"Posaconazole for chronic refractory coccidioidal meningitis","volume":"53","author":"Schein","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib91","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/cid\/ciz741","article-title":"Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism","volume":"70","author":"Nguyen","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.010_bib92","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1093\/jac\/dkaa366","article-title":"Management of posaconazole-induced pseudohyperaldosteronism","volume":"75","author":"Davis","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.010_bib93","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.010_bib94","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/jac\/dkm383","article-title":"Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model","volume":"60","author":"Gonzalez","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2021.03.010_bib95","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/cid\/cit113","article-title":"Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series","volume":"56","author":"Levy","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.idc.2021.03.010_bib96","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated Coccidioidomycosis treated with interferon-gamma and dupilumab","volume":"382","author":"Tsai","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2021.03.010_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00999-18","article-title":"The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.010_bib98","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/13693786.2013.770610","article-title":"Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs","volume":"51","author":"Shubitz","year":"2013","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.010_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01715-18","article-title":"APX001 and Other Gwt1 inhibitor prodrugs are effective in experimental Coccidioides immitis pneumonia","volume":"63","author":"Viriyakosol","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.010_bib100","first-page":"28","article-title":"Aspiring antifungals: review of current antifungal pipeline developments","volume":"6","author":"Gintjee","year":"2020","journal-title":"J\u00a0Fungi (Basel)"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:13Z","timestamp":1760196553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552021000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0891552021000209"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.010","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coccidioidomycosis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}